Industries > Pharma > Global Infusion Devices Market Forecast to 2027

Global Infusion Devices Market Forecast to 2027

Infusion Pumps, Insulin Pumps, Enteral Feeding Pumps, other Infusion Pumps

PUBLISHED: 15 December 2017
PAGES: 231
PRODUCT CODE: PHA0268

Clear
WOOCS 2.2.1

The global infusion devices market is expected to grow at a CAGR of 6.2% in the first half of the forecast period. In 2016, the insulin pumps submarket held the 31% of the global infusion devices market.

How this report will benefit you
Read on to discover how you can exploit the future business opportunities emerging in this sector.

In this brand new 231-page report you will receive 83 tables and 65 figures – all unavailable elsewhere.

The 231-page report provides clear detailed insight into the global infusion devices market. Discover the key drivers and challenges affecting the market.

By ordering and reading our brand new report today you stay better informed and ready to act.

Report Scope

• Global Medical Infusion Devices market forecasts to 2027

• This report also breaks down the revenue forecast for global infusion devices market by these submarkets:
– Insulin pumps,
– Enteral feeding pumps
– Other pumps (a grouped category inclusive of chemotherapy pumps and PCA infusion pumps)

Global Infusion Devices Market Forecast to 2027

This report analyses and dicusses the drivers and restraints for each submarket.

• Our work also shows individual revenue forecasts to 2027 for 12 national markets:
– United States (US)
– Japan
– EU leaders
– Germany, France, the UK, Italy and Spain (EU5)
– BRIC nations – Brazil, Russia, India and China.
– South Korea
– RoW

• Our work also shows individual revenue forecasts to 2027 for the Global Drug Delivery Technology market, broken down by these submarkets:
– Oral drug delivery
– Inhalation drug delivery
– Injectable/implantable drug delivery
– Transdermal drug delivery
– Ocular drug delivery
– Nasal drug delivery

• This report discusses the leading products in the global infusion devices market, from several leading companies, including:
– ALCOR Scientific
– Altea Therapeutics
– Animas Corporation
– B.Braun
– Baxter
– CareFusion
– Cellnovo
– Covidien
– D. Medical Industries
– Danone Nutricia
– Debiotech
– Disetronic (Roche)
– Fresenius Kabi
– Hospira
– Insulet Corporation
– Johnson & Johnson
– Medline
– MedSolve Technologies
– Medtronic
– Q Core Medical
– Roche
– Smiths Medical
– SOOIL
– Tandem Diabetes Care
– Valeritas
– Zevex

• This report provides a SWOT analysis of the major strengths and weaknesses of the market, together with the opportunities available and the key threats faced. Moreover, this report proves Porter’s Five Forces Analysis of the global infusion devices market.

Visiongain’s study is for everybody needing commercial analyses for the Infusion Pumps market and leading companies. You will find data, trends and predictions. Please order our report now.

Visiongain is a trading partner with the US Federal Government
CCR Ref number: KD4R6

Download sample pages

Complete the form below to download your free sample pages for Global Infusion Devices Market Forecast to 2027


Download sample pages

Complete the form below to download your free sample pages for Global Infusion Devices Market Forecast to 2027


Latest Pharma news

Visiongain Publishes Single-Cell Analysis Market Report 2022-2032

The global single cell analysis market was valued at US$3,255.0 million in 2022 and is projected to grow at a CAGR of 15.1% during the forecast period 2022-2032.

26 May 2022

READ

Visiongain Publishes Ophthalmic Devices Market Report 2022-2032

The number of people who are blind or have poor vision is expected to rise considerably in the coming years. The growing elderly population is one of the key drivers of the Ophthalmic Devices Market’s upward trend.

19 April 2022

READ

Visiongain Publishes Vaccine Contract Manufacturing Market Report 2022-2032

The growing global health system has made significant contributions to protecting and promoting human health. However, long-standing, developing, and reemerging infectious disease risks continue to plague the planet

13 April 2022

READ

Visiongain Publishes Pharmaceutical Contract Manufacturing Market Report 2022-2032

The major driving factor contributing towards the growth of pharmaceutical contract manufacturing market are increase in investments in pharmaceutical R&D, rise in number of patent expiry, rising demand of generic drugs, and investment in advanced manufacturing technologies. However, use of serialization can thwart the market growth.

13 April 2022

READ

Categories